Sanger Release - zebrafish sequencing
Don Powell
don at sanger.ac.uk
Tue Nov 21 12:08:42 EST 2000
Sanger Centre to sequence zebrafish
genome in new Wellcome Trust
Initiative
Powerful model organism for genetics,
development
In a major new initiative, the Wellcome Trust announced that the
next target for genome sequencing would be a small fish called the
zebrafish [image available]. With a genome only half the size of
that of mouse or human, the zebrafish will play a key role in finding
genes in the other genomes. The new project is predicted to take
three years.
The announcement closely follows a Workshop held at the
Wellcome Trust Genome Campus =96 home of the Sanger Centre =96
attended by international scientists in the zebrafish research
community.
The small zebrafish is a powerful force in biology. Adults are about
4 cm long, the female can lay 200 eggs per week, and the
embryos are transparent and reach maturity in 2=963 months.
Exquisitely precise tools have been developed to generate and
analyse alterations in the zebrafish genome. In combination, these
features mean that exchange of sequence information between
human and zebrafish projects will accelerate progress in each. The
humble zebrafish will be used to find meaning for the code in the
human genome.
Leonard I Zon, MD, Children=92s Hospital of Boston MA, said, =92One of
the great advantages of zebrafish is the ability to produce, very
readily, mutations that are relevant to human health and disease.
This genomics initiative will superimpose those mutations on
disease loci identified through the work of the Human Genome
Project.=92 Development of blood cells is one example where
mutations in the zebrafish genome closely resemble human
disease such as anaemia or thalassaemia.
Professor Christiane N=FCsslein-Volhard, from the Max-Planck
Institute in T=FCbingen, Germany, said, =91Zebrafish is the ideal
organism to study the function of human genes,=92 Professor
N=FCsslein-Volhard, Nobel Prize Winner in 1995, is studying the way
the body plan is laid down during development. The T=FCbingen group
has identified more than 1000 mutations in the zebrafish, many of
which affect processes with great relevance to human physiology
and disease, such as heart function, hearing, blood formation,
vision, cartilage and bone formation, nervous system development.
These are now studied in many laboratories worldwide.
Professor Philip Ingham, University of Sheffield, UK, said,
=91Sequencing the zebrafish genome will provide a rapid route to
discovering the molecular basis of these mutations and hence to
an understanding of the biochemical function of the genes which
they identify.=92 One area of Professor Ingham=92s research is an
important gene in development called sonic hedgehog: mutations in
this gene cause one of the most common forms of human birth
defect, holoprosencephaly.
Dr Michael Dexter, Director of the Wellcome Trust, said, =91This
builds on the seminal work, supported by the Wellcome Trust, on
the human genome sequencing project and will help all our future
studies on gene function, leading to health care benefits.=92
Many genes are similar between genomes of human and those of
less complex animals. The genomic information from the worm C.
elegans, the first animal to be sequenced, has been used to find
Alzheimer=92s genes. However, the worm and the fly Drosophila do
not possess many of the complex organ systems found in higher
organisms. Being a vertebrate, the zebrafish (Danio rerio) has
blood, kidney and optical systems that share many features of the
human systems. Work on this organism will complement that on
the mouse, which is the most widely used mammalian genetic
model organism. The Sanger Centre and the Wellcome Trust are
also participating in an international consortium to sequence the
mouse (press release 6 October).
Layering of genomic information of different species =96 comparative
genomics =96 is an especially useful method for identifying genes
and gene control regions because similarities are revealed. If the
organism provides unique methods for biological study =96 as do both
the zebrafish and the mouse =96 then the combination of biological
and sequence information can advance research more rapidly.
As with all projects undertaken by the Sanger Centre and the
Wellcome Trust, the sequence information will be released rapidly,
and made available to researchers without cost or restriction.
1. The Wellcome Trust is the world=92s largest medical
research charity with an annual spend of some =A3600
million in financial year 1999/2000. The Wellcome Trust
supports more than 5000 researchers at 300 locations
in 42 different countries, laying the foundations for the
healthcare advances of the 21st century and helping to
maintain the UK=92s reputation as one of the worlds
leading scientific nations. As well as funding major
initiatives in the public understanding of science, the
Wellcome Trust is the country=92s leading supporter of
research into the history of medicine.
http://www.wellcome.ac.uk
More information about the Zbrafish
mailing list